Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04187651

PRP Use in Treatment of Fistula Ano

In treatment of perianal fistula several methods are described. However, since the Hippocrates basics of surgical treatment has not changed very much. the aim of this study is to evaluate the effectiveness of PRP gel in treatment of perianal fistula.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Uşak University

Uşak, 64100, Turkey (Türkiye)

About this study

Perianal fistula is a chronic condition that seriously affects the patients' quality of life. There are different treatment modalities used in treatment. Recently sphincter preserving methods are becoming more popular with low complication rates. Most of this methods aiming the closure of fistula tract by different pathways.

Platelet rich plasma (PRP) is used in a wide range of conditions in medicine. The investigator's team showed the effective treatment of pilonidal disease by use of PRP gel. In the recent study, aim to evaluate the effectiveness of PRP gel in treatment of perianal fistula.

Patients with perianal fistula will be evaluated for the study. After taking permission with informed consent; cases will be included in the study. Cases with inflammatory bowel disease, platelet function disorders or connective tissue disorders that may alter wound healing will be excluded from the study.

After, PRP application to the fistula tract patients will be taken to follow up. Perianal fistulas will be followed by magnetic resonance imaging 1 month after the application. Pre-application and post-application scans will be used for the evaluation of the treatment success.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with perianal fistula
  • signing the informed consent form
  • above the age of 18

Exclusion criteria

  • inflammatory bowel disease
  • previous radiation therapy
  • having connective tissue disorders

Treatment and study plan

Platelet Rich Plasma

Other

platelet rich plasma prepared from the patients' own blood will be applied to the fistula tract

Primary outcomes

  1. percentage of the cure rate

    Time frame: 1 month

    closure of the fistula tract will be evaluated by physical examination and magnetic resonance imaging

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Official study title

Use of Platelet Rich Plasma in Treatment of Perianal Fistula

Important dates

Study start
2019
Primary completion
2025
Study completion
2026
First posted
Dec 5, 2019
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.